Ownership history in CITIGROUP INC · 8 quarters on record
This page tracks every 13F SEC filing in which CITIGROUP INC reported a position in CARISMA THERAPEUTICS INC (CARM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 11,274 | +11,264 | +112640.0% | 0.00% | $3K | $0.27 |
| 2024 Q4 | UNCHANGED | 10 | — | 0% | 0.00% | $4 | $0.42 |
| 2024 Q3 | REDUCED | 10 | -3,502 | -99.7% | 0.00% | $10 | $0.98 |
| 2024 Q2 | REDUCED | 3,512 | -1,487 | -29.7% | 0.00% | $5K | $1.52 |
As of 2025 Q4 — sorted by position size